The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.

Slides:



Advertisements
Similar presentations
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research February 4, 2013 Vol.
Advertisements

Slide 1 Healthcare Utilization and Mortality associated with HIV and HCV: How to address the burden of liver disease Susanna Naggie 1,2, Lawrence Park.
PERMEATING BORDERS OVERDOSE PREVENTION Summer Conference 2014 July 24, 2014 ACOPC Allegheny County Overdose Prevention Coalition Presents.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
MaineCare’s New Medication Assisted Treatment (MAT)/Methadone Maintenance Therapy (MMT) Policy Kevin S. Flanigan, MD Medical Director Office of MaineCare.
The Challenge of Opioid Addiction Valerie Valcour RN, Health District Director Carol Plante, Healthy Lamoille Valley * September 3, 2014.
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
Controlled Substance Prescribing Trends and Physician and Pharmacy Utilization Patterns: Epidemiological Analysis of the Maine Prescription Monitoring.
Recovery Housing and The National Drug Control Strategy David K. Mineta Deputy Director, Demand Reduction Office of National Drug Control Policy (ONDCP)
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
The Redesigned National Hospital Discharge Survey National Center for Health Statistics Division of Health Care Statistics Hospital Care Team Last Updated:
CHAPTER 9 Primary Liver Cancer Source: Burden of digestive diseases in the United States, NIH Publication No
Serving our community by improving health The Addiction Crisis November 2014.
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
1. 2 National Institute on Drug Abuse Community Epidemiology Work Group (CEWG) Established 1976.
From the Monitoring the Future Study Report: The University of Michigan 2012.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Broward County Report Substance Abuse Issues and Trends – Winter 2013 James N. Hall.
H.R Prescription drug abuse prevention and treatment Act of 2011.
SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.
CHAPTER 3 Viral Hepatitis Source: Burden of digestive diseases in the United States, NIH Publication No
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
State of the State in outcomes: Prescription drug overdoses Karin A. Mack, PhD Senior Behavioral Scientist Prescription Drug Overdose Team National Center.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,
SARAH M. BAGLEY, MD ASSISTANT PROFESSOR OF MEDICINE AND PEDIATRICS BOSTON UNIVERSITY SCHOOL OF MEDICINE AMERSA ANNUAL CONFERENCE NOVEMBER 5, 2015 Overdose.
DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.
CHAPTER 11 Cancer of the Gallbladder Source: Burden of digestive diseases in the United States, NIH Publication No
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Increasing Midlife Mortality: What Does it Say About U.S. Society? Sociology Chapter 21: Health and Medicine Society: The Basics Chapter 14: Education,
Peterson-Kaiser Health System Tracker What are the current costs and outcomes related to mental health and substance abuse disorders?
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
1 READY BY 21 TASKFORCE Harford County Department of Community Services Local Management Board Health Benchmark December 7, 2010.
Considerations for NJ Psychiatric Rehabilitation Association NJ Behavioral Health Planning Council NJ DMHAS Citizens Advisory Council Tom Pyle MBA, MS,
Considerations for NJ Behavioral Health Planning Council and Citizens Advisory Council Tom Pyle MBA, MS, CPRP Psychodyssey Services
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible.
State Targeted Response to Opioid Crisis
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Medication-Assisted Therapy at Coleman Profession Services
McLean Hospital Division of Alcohol and Drug Abuse
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
Opioids – A Pharmaceutical Perspective on Prescription Drugs
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
Addiction and the Opioid Crisis: HHS Update
ROOM project Addressing the Opioid Epidemic in the U.P.
The Myths and Realities of the Opioid Epidemic AMERSA November 3, 2017
6th Annual Residential Substance Abuse Treatment Conference
Jonathan Mermin, MD, MPH RADM, USPHS
Opioids in Butte County
Pain Management and Substance Use Disorders: JCPP Strategic Session
The Complex Relationships Among Race/Ethnicity, Social Determinants, and Prescription Opioid Utilization Lanlan Xu, IMPAQ International.
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
buprenorphine-naloxone
New Jersey Addictions Charts and Graphs (v. 1.0, as of March 15, 2016)
Alcohol, Other Drugs, and Health: Current Evidence
Strategic Initiatives to Address Opioid Overdose & Addiction
Data Sources ADH: Other AR Data: National: Vital Statistics PDMP
Presentation transcript:

The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School for Social Policy and Management, Brandeis University

Conflict of Interests 2 I have no relevant financial relationships to disclose.

3 Incidence of non-medical use of pain relievers has been declining since 2002 Source: Kolodny et al. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction. Annu Rev Public Health. 2015: 36:

Estimated Age-adjusted Death Rates for Drug Poisoning by County SOURCE: CDC/NCHS, National Vital Statistics System; Tom Frieden Presentation at the Opioid Summit, Atlanta, April 2016

5Source: Kolodny et al. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction. Annu Rev Public Health. 2015: 36: Non-medical Rx opioid use vs. opioid Rx OD deaths by age group

Three Opioid-Addicted Cohorts y/o, disproportionately white, significant heroin use, opioid addiction began with Rx use 2.40 y/o & up, disproportionately white, mostly Rx opioids, opioid addiction began with Rx use 3.50 y/o & up, disproportionately non-white, mostly heroin users, opioid addiction began with heroin use 6

Heroin treatment admissions : SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Data received through

8 Mortality by cause, white non-Hispanics ages 45–54 Source: Anne Case, Angus Deaton. Rising morbidity and mortality in midlife among white non- Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences. November 2, 2015 (online ahead of print).

9 Rate of hospital inpatient stays related to “opioid overuse”, 1993 and 2012 Source: Agency for Healthcare Research and Quality (AHRQ), Center for Delivery, Organization, and Markets, Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Sample (NIS), 1993 and 2012

Heroin admissions, by gender, age, and race/ethnicity: 2013 SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Data received through

Opioid Related Overdose Deaths United States,

Buprenorphine Experience in France Introduced in the mid 90s 79% decline in OD deaths in 6 years Use of mono product (not formulated with naloxone) associated with diversion and injection use Source: Auriacombe et al. French field experience with buprenorphine. Am J Addict. 2004

Heroin treatment admissions with planned medication-assisted opioid therapy SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Data received through

Barriers to Buprenorphine Ideological Federally imposed patient caps Federally imposed ban on NP and PA prescribing Limited integration of addiction treatment in primary care Prior authorization requirements

Questions?